Align Technology | ALGN - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
3M USD 3.26B 1.66B 2026-03
Align Technology USD 862.03M 39.18M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
CVS Health USD 95.75B 7.84B 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Dexcom USD 936.6M 0 2026-03
Henry Schein USD 3.17B 77M 2026-03
Idexx Laboratories USD 778.23M 3.26M 2026-03
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
McKesson USD 94.46B 10.04B 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Solventum Corp USD 4.97B 3.08B 2026-03
Stryker USD 4.92B 284M 2026-03
Teleflex USD 3.08B 2.55B 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Veeva Systems USD 609.84M 19.76M 2026-03
Waters USD 1.12B 457.15M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03
Zoetis USD 3.23B 1.68B 2026-03